CompletedNot Applicable

Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes

12 participantsStarted 2015-01-14

Plain-language summary

The purpose of the study is to determine the effects of insulin suspension at start of exercise in individuals with type 1 diabetes. A total of 3 sessions will be required for this project. The first will be a familiarization session that requires completed informed consent, anthropometric measurements (height, weight, body fat percentage), questionnaires, and a test of maximal aerobic fitness. The remaining 2 sessions will be steady-state aerobic exercise as well as circuit exercise.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have had diabetes for \> 1 year * Currently treated with continuous subcutaneous insulin infusion (CSII)/insulin pump therapy for at least 6 months * Fair-to-good glycemic control (last HbA1c ≤ 9.0%) Exclusion Criteria: * Frequent and unpredictable hypoglycemia * Unable to exercise on a regular basis due to an injury or other restriction * Using an insulin pump and switch to injections (or vice versa) in the last two months * Have conditions that would make exercise unsafe (e.g. high blood pressure) * Take medications in the class of drugs called 'beta-blockers' * A woman who is pregnant, planning pregnancy, or breastfeeding

What they're measuring

Blood glucose concentrations

Timeframe: Approximately 2 hours

Trial details

NCT IDNCT03034798

SponsorYork University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-07-28

View on ClinicalTrials.gov More Type1 Diabetes Mellitus trials